BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32627043)

  • 1. Antihypertensive drug telmisartan suppresses the proliferation of gastric cancer cells in vitro and in vivo.
    Fujita N; Fujita K; Iwama H; Kobara H; Fujihara S; Chiyo T; Namima D; Yamana H; Kono T; Takuma K; Hirata M; Kobayashi K; Kato K; Kamada H; Morishita A; Tsutsui K; Himoto T; Okano K; Suzuki Y; Masaki T
    Oncol Rep; 2020 Jul; 44(1):339-348. PubMed ID: 32627043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.
    Fujihara S; Morishita A; Ogawa K; Tadokoro T; Chiyo T; Kato K; Kobara H; Mori H; Iwama H; Masaki T
    Oncotarget; 2017 Jan; 8(5):8536-8549. PubMed ID: 28052030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo.
    Kato K; Gong J; Iwama H; Kitanaka A; Tani J; Miyoshi H; Nomura K; Mimura S; Kobayashi M; Aritomo Y; Kobara H; Mori H; Himoto T; Okano K; Suzuki Y; Murao K; Masaki T
    Mol Cancer Ther; 2012 Mar; 11(3):549-60. PubMed ID: 22222629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
    Samukawa E; Fujihara S; Oura K; Iwama H; Yamana Y; Tadokoro T; Chiyo T; Kobayashi K; Morishita A; Nakahara M; Kobara H; Mori H; Okano K; Suzuki Y; Himoto T; Masaki T
    Int J Oncol; 2017 Dec; 51(6):1674-1684. PubMed ID: 29075786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer.
    Yawata K; Osada S; Tanahashi T; Matsui S; Sasaki Y; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K
    Anticancer Res; 2016 Oct; 36(10):5215-5226. PubMed ID: 27798882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive drug telmisartan inhibits cell proliferation of gastrointestinal stromal tumor cells in vitro.
    Kobara H; Fujihara S; Iwama H; Matsui T; Fujimori A; Chiyo T; Tingting S; Kobayashi N; Nishiyama N; Yachida T; Tadokoro T; Oura K; Tani J; Fujita K; Nomura T; Yoneyama H; Morishita A; Okano K; Suzuki Y; Mori H; Masaki T
    Mol Med Rep; 2020 Aug; 22(2):1063-1071. PubMed ID: 32626983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo.
    Matsui T; Chiyo T; Kobara H; Fujihara S; Fujita K; Namima D; Nakahara M; Kobayashi N; Nishiyama N; Yachida T; Morishita A; Iwama H; Masaki T
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
    Oura K; Tadokoro T; Fujihara S; Morishita A; Chiyo T; Samukawa E; Yamana Y; Fujita K; Sakamoto T; Nomura T; Yoneyama H; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Masaki T
    Oncol Rep; 2017 Nov; 38(5):2825-2835. PubMed ID: 29048654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells.
    Yamana Y; Fujihara S; Kobara H; Oura K; Samukawa E; Chiyo T; Okamura M; Yamana H; Tadokoro T; Fujita K; Morishita A; Iwama H; Masaki T
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S305-S312. PubMed ID: 36510981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin.
    Kato K; Iwama H; Yamashita T; Kobayashi K; Fujihara S; Fujimori T; Kamada H; Kobara H; Masaki T
    Oncol Rep; 2016 Mar; 35(3):1582-92. PubMed ID: 26708419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan Exerts Cytotoxicity in Scirrhous Gastric Cancer Cells by Inducing G
    Tsujiya Y; Yamamori M; Hasegawa AI; Yamamoto Y; Yashiro M; Okamura N
    Anticancer Res; 2021 Nov; 41(11):5461-5468. PubMed ID: 34732415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling.
    Fan HN; Zhu MY; Peng SQ; Zhu JS; Zhang J; Qu GQ
    Pathol Res Pract; 2020 Feb; 216(2):152795. PubMed ID: 31879047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.
    Chen SH; Gong X; Zhang Y; Van Horn RD; Yin T; Huber L; Burke TF; Manro J; Iversen PW; Wu W; Bhagwat SV; Beckmann RP; Tiu RV; Buchanan SG; Peng SB
    Oncogene; 2018 Feb; 37(6):821-832. PubMed ID: 29059158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
    Hu J; Fang Y; Cao Y; Qin R; Chen Q
    Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
    Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
    J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
    Zheng Z; Yan D; Chen X; Huang H; Chen K; Li G; Zhou L; Zheng D; Tu L; Dong XD
    PLoS One; 2015; 10(7):e0128751. PubMed ID: 26186594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.
    Li T; Zhao X; Mo Z; Huang W; Yan H; Ling Z; Ye Y
    Cell Physiol Biochem; 2014; 34(4):1351-8. PubMed ID: 25301361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells.
    Du B; Wang Z; Zhang X; Feng S; Wang G; He J; Zhang B
    PLoS One; 2014; 9(2):e88022. PubMed ID: 24505359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
    Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
    Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.